Exciting new cancer drug kinder than chemotherapy
Arthur, 11, was one of the first in the UK to try blinatumomab, for his type of blood cancer.
Similar Posts
Alzheimer’s patients divided into 5 subgroups, potentially enabling ‘personalized medicine,’ study finds
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
AI-designed drug for inflammatory bowel disease enters human clinical trials: ‘A significant need’
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Isolating sooner might have avoided first lockdown, Hunt says
The UK should have prepared to test and isolate more, the ex-health secretary tells the Covid inquiry.
Renewed interest in ADCs will continue in 2024
Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to the treatments to fuel growth in the year ahead….
Vaping: How do you quit e-cigarettes?
It can get you off tobacco – but what do you do when you want to say bye to your e-cig?
Brain tumor patient plays guitar during surgery: ‘This is wild’
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…